Oppenheimer & Co’s IRIDEX IRIX Stock Holding History

Oppenheimer & Co’s Portfolio IRIX Stock Details IRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,000	Closed	-$114K	–	1320
2015 Q3	$114K	Hold	15,000	–	–	﹤0.01%	1252
2015 Q2	$124K	Hold	15,000	–	–	﹤0.01%	1385
2015 Q1	$160K	Hold	15,000	–	–	﹤0.01%	1358
2014 Q4	$129K	Hold	15,000	–	–	﹤0.01%	1306
2014 Q3	$105K	Hold	15,000	–	–	﹤0.01%	1343
2014 Q2	$125K	Hold	15,000	–	–	﹤0.01%	1330
2014 Q1	$134K	Sell	15,000 -11,455	-43%	-$105K	﹤0.01%	1305
2013 Q4	$269K	Buy	26,455 +14,794	+127%	+$118K	0.01%	1051
2013 Q3	$69K	Hold	11,661	–	–	﹤0.01%	1268
2013 Q2	$69K	Buy	+11,661	New	+$62.5K	﹤0.01%	1223

Other funds holding IRIX

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return

CAD

Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Oppenheimer & Co's IRIX Position: Q4 2015 in Review

Oppenheimer & Co sold out of IRIDEX (IRIX) in Q4 2015, closing a stake of 15,000 shares — an estimated $114K sold.

Oppenheimer & Co first reported a position in IRIX in Q2 2013 and held it in 10 quarters. The position peaked at $269K in Q4 2013. 25 funds tracked by Wall St. Rank hold IRIX as of Q4 2015.

Oppenheimer & Co reported no remaining IRIDEX position as of Q4 2015 after selling out during the quarter.
Oppenheimer & Co sold 15,000 IRIDEX shares in Q4 2015, an estimated $114K.
Oppenheimer & Co first reported a position in IRIDEX in Q2 2013 and held it in 10 quarters.
Oppenheimer & Co's IRIDEX position peaked at $269K in Q4 2013.
25 funds tracked by Wall St. Rank held IRIDEX as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.